2024
Extracellular Vesicles and Proteomics
Liquid biopsy applications of proteomics
2023
Bioinformatic approaches for clinical proteomics: too many choices and no standardization
Clinical translation of targeted proteomics
Featured article: "Early detection of breast cancer through the diagnosis of Nipple Aspirate Fluid (NAF)"
Cases of breast cancer have also been reported in younger women and the leading cause in them is their lifestyle pattern or they may be carriers of high penetrance mutated genes.Classification, diagnosis, and prediction of the outcomes have been made through tissue and serum biomarkers but these also fail to diagnose the disease at an early stage. Considerably there is no adequate detection technique present globally that can help early detection and provide adequate specificity, safety, sensitivity, and convenience for the younger and premenopausal women, thereby it becomes necessary to take early measures and build efficient tools and techniques for the same. Through biopsies of nipple aspirate fluid (NAF) biomarker profiling can be performed. NAF can help display a paradigm shift in the management of breast cancer which can help women patients to self-analyze breast cancer development.
Articles
-
-
Characterizing age-related changes in intact mitochondrial proteoforms in murine hearts using quantitative top-down proteomics
-
Biomarker discovery in progressive supranuclear palsy from human cerebrospinal fluid
-
Research biopsies in kidney transplantation: an evaluation of surgical techniques and optimal tissue mass allowing molecular and histological analyses
-
Using established biorepositories for emerging research questions: a feasibility study
-
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
-
Basics and recent advances of two dimensional- polyacrylamide gel electrophoresis
-
Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
-
Nanotechnologies in Glycoproteomics
-
Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources
The Correction to this article has been published in Clinical Proteomics 2024 21:20
Archival content
In 2011, Clinical Proteomics converted from a subscription publication to a fully open access journal. The journal's back content can be viewed on SpringerLink.
Calls for Papers
Aims and scope
Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.
Editor's profile
Dr Daniel W Chan is currently Professor of Pathology, Oncology, Urology, and Radiology at Johns Hopkins Medical Institutions, and Director of the Clinical Chemistry Division, Co-Director at the Pathology Core Laboratory, and Director at the Center for Biomarker Discovery and Translation at the Johns Hopkins University School of Medicine. He has worked extensively on the development and application of proteomic and immunologic techniques in the understanding of cancer. As the author of five books and over 300 articles, Dr Chan has become established as a leading expert in clinical proteomics and cancer research. Dr Chan is an active member of US Human Proteome Organization (USHUPO), American Association for Cancer Research (AACR) and American Association for Clinical Chemistry (AACC).
Trezvuy - Fotolia
Have an idea for a new thematic series?
Make a suggestion here
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.8
5-year Journal Impact Factor: 3.9
Source Normalized Impact per Paper (SNIP): 0.831
SCImago Journal Rank (SJR): 1.015Speed 2023
Submission to first editorial decision (median days): 10
Submission to acceptance (median days): 159Usage 2023
Downloads: 434,196
Altmetric mentions: 385